-
1
-
-
0031756899
-
New concepts in renal osteodystrophy
-
Hruska K. New concepts in renal osteodystrophy. Nephrol Dial Transplant 1998;13:2755-60.
-
(1998)
Nephrol Dial Transplant
, vol.13
, pp. 2755-2760
-
-
Hruska, K.1
-
2
-
-
0027485515
-
Aplastic osteodystrophy without aluminum: The role of "suppressed" parathyroid function
-
Hercz G, Pei Y, Greenwood C, et al. Aplastic osteodystrophy without aluminum: the role of "suppressed" parathyroid function. Kidney Int 1993;44:860-6.
-
(1993)
Kidney Int
, vol.44
, pp. 860-866
-
-
Hercz, G.1
Pei, Y.2
Greenwood, C.3
-
3
-
-
0019763039
-
Bone histomorphometry in hemodialysed patients
-
DeVernejoul MC, Kuntz D, Miravet L, Gueris J, Bielakoff J, Ryckewaert A. Bone histomorphometry in hemodialysed patients. Metab Bone Dis Rel Res 1981;3:175-9.
-
(1981)
Metab Bone Dis Rel Res
, vol.3
, pp. 175-179
-
-
DeVernejoul, M.C.1
Kuntz, D.2
Miravet, L.3
Gueris, J.4
Bielakoff, J.5
Ryckewaert, A.6
-
4
-
-
0026936519
-
Short and long-term efficacy of total parathyroidectomy with immediate autografting compared with subtotal parathyroidectomy in hemodialysis patients
-
Gagné ER, Ureña P, Leite-Silva S, et al. Short and long-term efficacy of total parathyroidectomy with immediate autografting compared with subtotal parathyroidectomy in hemodialysis patients. J Am Soc Nephrol 1992;3:1008-17.
-
(1992)
J Am Soc Nephrol
, vol.3
, pp. 1008-1017
-
-
Gagné, E.R.1
Ureña, P.2
Leite-Silva, S.3
-
5
-
-
0000795191
-
Single doses of the calcimimetic AMG-073 reduce parathyroid hormone levels in a dose-dependent manner in hemodialysis patients with secondary hyperparathyroidism
-
Coburn J, Barri Y, Turner S, et al. Single doses of the calcimimetic AMG-073 reduce parathyroid hormone levels in a dose-dependent manner in hemodialysis patients with secondary hyperparathyroidism. J Am Soc Nephrol 2000;11:573A.
-
(2000)
J Am Soc Nephrol
, vol.11
-
-
Coburn, J.1
Barri, Y.2
Turner, S.3
-
6
-
-
0032516837
-
Protein kinase C phosphorylation of threonine at position 888 in Ca2+-sensing receptor (CaR) inhibits coupling to Ca2+ store release
-
Bai M, Trivedi S, Lane CR, Yang Y, Quinn SJ, Brown EM. Protein kinase C phosphorylation of threonine at position 888 in Ca2+-sensing receptor (CaR) inhibits coupling to Ca2+ store release. J Biol Chem 1998;273:21267-75.
-
(1998)
J Biol Chem
, vol.273
, pp. 21267-21275
-
-
Bai, M.1
Trivedi, S.2
Lane, C.R.3
Yang, Y.4
Quinn, S.J.5
Brown, E.M.6
-
7
-
-
0036411684
-
Treatment of secondary hyperparathyroidism with vitamin D derivatives and calcimimetics before and after start of dialysis
-
Drueke TB. Treatment of secondary hyperparathyroidism with vitamin D derivatives and calcimimetics before and after start of dialysis. Nephrol Dial Transplant 2002;17(suppl 11):20-2.
-
(2002)
Nephrol Dial Transplant
, vol.17
, Issue.11 SUPPL.
, pp. 20-22
-
-
Drueke, T.B.1
-
8
-
-
0027765508
-
Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid
-
Brown EM, Gamba G, Riccardi D, et al. Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature 1993;366:575-80.
-
(1993)
Nature
, vol.366
, pp. 575-580
-
-
Brown, E.M.1
Gamba, G.2
Riccardi, D.3
-
9
-
-
0028946265
-
Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia
-
Arnold A, Brown M, Ureña P, Gaz R, Sarfati E, Drüeke T, Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest 1995;95:2047-54.
-
(1995)
J Clin Invest
, vol.95
, pp. 2047-2054
-
-
Arnold, A.1
Brown, M.2
Ureña, P.3
Gaz, R.4
Sarfati, E.5
Drüeke, T.6
-
10
-
-
0032985183
-
The calcimimetic NPS R-568 decreases plasma PTH in rats with mild and severe renal or dietary secondary hyperparathyroidism
-
Fox J, Lowe SH, Conklin RL, Nemeth EF. The calcimimetic NPS R-568 decreases plasma PTH in rats with mild and severe renal or dietary secondary hyperparathyroidism. Endocrine 1999;10:97-103.
-
(1999)
Endocrine
, vol.10
, pp. 97-103
-
-
Fox, J.1
Lowe, S.H.2
Conklin, R.L.3
Nemeth, E.F.4
-
11
-
-
0033175760
-
Structure and function of the extracellular calcium-sensing receptor
-
Bai M. Structure and function of the extracellular calcium-sensing receptor (Review). Int J Mol Med 1999;4:115-25.
-
(1999)
Int J Mol Med
, vol.4
, pp. 115-125
-
-
Bai, M.1
-
12
-
-
0032483541
-
Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells
-
Bai M, Trivedi S, Brown EM. Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells. J Biol Chem 1998;273:23605-10.
-
(1998)
J Biol Chem
, vol.273
, pp. 23605-23610
-
-
Bai, M.1
Trivedi, S.2
Brown, E.M.3
-
13
-
-
0032987986
-
Extracellular "calcistat" in health and disease
-
Pearce S. Extracellular "calcistat" in health and disease. Lancet 1999;353:83-4.
-
(1999)
Lancet
, vol.353
, pp. 83-84
-
-
Pearce, S.1
-
14
-
-
0032982710
-
No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas
-
Cetani F, Pinchera A, Pardi E, et al. No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas. J Bone Miner Res 1999;14:878-82.
-
(1999)
J Bone Miner Res
, vol.14
, pp. 878-882
-
-
Cetani, F.1
Pinchera, A.2
Pardi, E.3
-
15
-
-
0028826364
-
Mutational analysis of the extracellular Ca2+-sensing receptor gene in human parathyroid tumors
-
Hosokawa Y, Pollak M, Brown E, Arnold A. Mutational analysis of the extracellular Ca2+-sensing receptor gene in human parathyroid tumors. J Clin Endocrinol Metab 1995;80:3107-10.
-
(1995)
J Clin Endocrinol Metab
, vol.80
, pp. 3107-3110
-
-
Hosokawa, Y.1
Pollak, M.2
Brown, E.3
Arnold, A.4
-
16
-
-
0031042732
-
Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism
-
Gogusev J, Duchambon P, Hory B, et al. Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int 1997;51:328-36.
-
(1997)
Kidney Int
, vol.51
, pp. 328-336
-
-
Gogusev, J.1
Duchambon, P.2
Hory, B.3
-
17
-
-
0029873489
-
Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism
-
Kifor O, Moore F, Wang P, et al. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 1996;81:1598-606.
-
(1996)
J Clin Endocrinol Metab
, vol.81
, pp. 1598-1606
-
-
Kifor, O.1
Moore, F.2
Wang, P.3
-
18
-
-
0034783848
-
Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism
-
Valimaki S, Farnebo F, Forsberg L, Larsson C, Farnebo LO. Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism. Kidney Int 2001;60:1666-75.
-
(2001)
Kidney Int
, vol.60
, pp. 1666-1675
-
-
Valimaki, S.1
Farnebo, F.2
Forsberg, L.3
Larsson, C.4
Farnebo, L.O.5
-
19
-
-
0036895625
-
Reversal of secondary hyperparathyroidism by phosphate restriction restores parathyroid calcium-sensing receptor expression and function
-
Ritter CS, Martin DR, Yan L, Slatopolsky EA, Brown AJ. Reversal of secondary hyperparathyroidism by phosphate restriction restores parathyroid calcium-sensing receptor expression and function. J Bone Min Res 2002;17:2206-13.
-
(2002)
J Bone Min Res
, vol.17
, pp. 2206-2213
-
-
Ritter, C.S.1
Martin, D.R.2
Yan, L.3
Slatopolsky, E.A.4
Brown, A.J.5
-
20
-
-
0036066178
-
Persistent downregulation of calcium-sensing receptor mRNA in rat parathyroids when severe secondary hyperparathyroidism is reversed by an isogenic kidney transplantation
-
Lewin E, Garfia B, Recio FL, Rodriguez M, Olgaard K. Persistent downregulation of calcium-sensing receptor mRNA in rat parathyroids when severe secondary hyperparathyroidism is reversed by an isogenic kidney transplantation. J Am Soc Nephrol 2002;13:2110-6.
-
(2002)
J Am Soc Nephrol
, vol.13
, pp. 2110-2116
-
-
Lewin, E.1
Garfia, B.2
Recio, F.L.3
Rodriguez, M.4
Olgaard, K.5
-
21
-
-
0035860795
-
Interaction of the calcium-sensing receptor and filamin, a potential scaffolding protein
-
Awata H, Huang C, Handlogten ME, Miller RT. Interaction of the calcium-sensing receptor and filamin, a potential scaffolding protein. J Biol Chem 2001;276:34871-9.
-
(2001)
J Biol Chem
, vol.276
, pp. 34871-34879
-
-
Awata, H.1
Huang, C.2
Handlogten, M.E.3
Miller, R.T.4
-
22
-
-
0031595986
-
Allosteric activation of the Ca2+ receptor in Xenopus laevis oocytes by NPS 467 or NPS 568
-
Hammerland L, Garrett J, Hung B, Levinthal C, Nemeth E. Allosteric activation of the Ca2+ receptor in Xenopus laevis oocytes by NPS 467 or NPS 568. Mol Pharmacol 1998;53:1083-8.
-
(1998)
Mol Pharmacol
, vol.53
, pp. 1083-1088
-
-
Hammerland, L.1
Garrett, J.2
Hung, B.3
Levinthal, C.4
Nemeth, E.5
-
23
-
-
0037166287
-
Evidence for distinct cation and calcimimetic compound (NPS 568) recognition domains in the transmembrane regions of the human Ca2+ receptor
-
Ray K, Northup J. Evidence for distinct cation and calcimimetic compound (NPS 568) recognition domains in the transmembrane regions of the human Ca2+ receptor. J Biol Chem 2002;277:18908-13.
-
(2002)
J Biol Chem
, vol.277
, pp. 18908-18913
-
-
Ray, K.1
Northup, J.2
-
24
-
-
0034012178
-
Activation of the calcium receptor by a calcimimetic compound halts the progression of secondary hyperparathyroidism in uremic rats
-
Chin J, Miller SC, Wada M, Nagano N, Nemeth EF, Fox J. Activation of the calcium receptor by a calcimimetic compound halts the progression of secondary hyperparathyroidism in uremic rats. J Am Soc Nephrol 2000;11:903-11.
-
(2000)
J Am Soc Nephrol
, vol.11
, pp. 903-911
-
-
Chin, J.1
Miller, S.C.2
Wada, M.3
Nagano, N.4
Nemeth, E.F.5
Fox, J.6
-
25
-
-
0033962371
-
Daily intermittent decreases in serum leveis of parathyroid hormone have an anabolic-like action on the bones of uremic rats with low-turnover bone and osteomalacia
-
Ishii H, Wada M, Furuya Y, Nagano N, Nemeth EF, Fox J. Daily intermittent decreases in serum leveis of parathyroid hormone have an anabolic-like action on the bones of uremic rats with low-turnover bone and osteomalacia. Bone 2000;26:175-82.
-
(2000)
Bone
, vol.26
, pp. 175-182
-
-
Ishii, H.1
Wada, M.2
Furuya, Y.3
Nagano, N.4
Nemeth, E.F.5
Fox, J.6
-
26
-
-
0031888842
-
A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure. Rapid communication
-
Antonsen JE, Sherrard DJ, Andress DL. A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure. Rapid communication. Kidney Int 1998;53:223-7.
-
(1998)
Kidney Int
, vol.53
, pp. 223-227
-
-
Antonsen, J.E.1
Sherrard, D.J.2
Andress, D.L.3
-
27
-
-
0031466527
-
The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor
-
Wada M, Furuya Y, Sakiyama J, et al. The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor. J Clin Invest 1997;100:2977-83.
-
(1997)
J Clin Invest
, vol.100
, pp. 2977-2983
-
-
Wada, M.1
Furuya, Y.2
Sakiyama, J.3
-
28
-
-
0031885412
-
NPS R-568 halts or reverses osteitis fibrosa in uremic rats
-
Wada M, Ishii H, Furuya Y, Fox J, Nemeth EF, Nagano N. NPS R-568 halts or reverses osteitis fibrosa in uremic rats. Kidney Int 1998;53:448-53.
-
(1998)
Kidney Int
, vol.53
, pp. 448-453
-
-
Wada, M.1
Ishii, H.2
Furuya, Y.3
Fox, J.4
Nemeth, E.F.5
Nagano, N.6
-
29
-
-
0032892011
-
Mixed-effects modeling of the pharmacodynamic response to the calcimimetic agent R-568
-
Lalonde RL, Gaudreault J, Karhu DA, Marriott TB. Mixed-effects modeling of the pharmacodynamic response to the calcimimetic agent R-568. Clin Pharmacol Ther 1999;65:40-9.
-
(1999)
Clin Pharmacol Ther
, vol.65
, pp. 40-49
-
-
Lalonde, R.L.1
Gaudreault, J.2
Karhu, D.A.3
Marriott, T.B.4
-
30
-
-
0030667380
-
Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism
-
Silverberg SJ, Bone HG, III, Marriott TB, et al. Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism. N Engl J Med 1997;337:1506-10.
-
(1997)
N Engl J Med
, vol.337
, pp. 1506-1510
-
-
Silverberg, S.J.1
Bone H.G. III2
Marriott, T.B.3
-
31
-
-
0031763613
-
Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent
-
Collins MT, Skarulis MC, Bilezikian JP, Silverberg SJ, Spiegel AM, Marx SJ. Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent. J Clin Endocrinol Metab 1998;83:1083-8.
-
(1998)
J Clin Endocrinol Metab
, vol.83
, pp. 1083-1088
-
-
Collins, M.T.1
Skarulis, M.C.2
Bilezikian, J.P.3
Silverberg, S.J.4
Spiegel, A.M.5
Marx, S.J.6
-
32
-
-
0036208986
-
The calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism
-
Goodman WG, Hladik GA, Turner SA, et al. The calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism. J Am Soc Nephrol 2002;13:1017-24.
-
(2002)
J Am Soc Nephrol
, vol.13
, pp. 1017-1024
-
-
Goodman, W.G.1
Hladik, G.A.2
Turner, S.A.3
-
33
-
-
6444245707
-
The calcimimetic AMG-073 reduces parathyroid hormone (PTH), phosphorus, and calcium x phosphorus product in secondary hyperparathyroidism
-
Lindberg J, Moe S, Goodman W, et al. The calcimimetic AMG-073 reduces parathyroid hormone (PTH), phosphorus, and calcium x phosphorus product in secondary hyperparathyroidism. J Am Soc Nephrol 2002;63:248-54.
-
(2002)
J Am Soc Nephrol
, vol.63
, pp. 248-254
-
-
Lindberg, J.1
Moe, S.2
Goodman, W.3
-
34
-
-
0011866033
-
The calcimimetic AMG 073 reduces PTH and Ca x P in patients with secondary hyperparathyroidism (SHPT)
-
Quarles LD, Sherrard DJ, Adler S, et al. The calcimimetic AMG 073 reduces PTH and Ca x P in patients with secondary hyperparathyroidism (SHPT). J Am Soc Nephrol 2001;12:771A.
-
(2001)
J Am Soc Nephrol
, vol.12
-
-
Quarles, L.D.1
Sherrard, D.J.2
Adler, S.3
-
35
-
-
0041436109
-
The calcimimetic AMG-073: A potential novel therapy for secondary hyperparathyroidism (SHPT)
-
Block G, Coyne D, Goodman W, et al. The calcimimetic AMG-073: A potential novel therapy for secondary hyperparathyroidism (SHPT). J Am Soc Nephrol 2002;13:572A.
-
(2002)
J Am Soc Nephrol
, vol.13
-
-
Block, G.1
Coyne, D.2
Goodman, W.3
-
36
-
-
0042939223
-
Two-year treatment with the calcimimetic AMG-073 in hemodialysis patients with secondary hyperparathyroidism (SHPT)
-
Moe S, Sprague S, Adler S, et al. Two-year treatment with the calcimimetic AMG-073 in hemodialysis patients with secondary hyperparathyroidism (SHPT). J Am Soc Nephrol 2002;13:572A.
-
(2002)
J Am Soc Nephrol
, vol.13
-
-
Moe, S.1
Sprague, S.2
Adler, S.3
-
37
-
-
0042939223
-
The effects of one-year treatment with the calcimimetic AMG-073 on bone health in ESRD patients with secondary hyperparathyroidism (SHPT)
-
Quarles L, Spiegel D, Curzi M, et al. The effects of one-year treatment with the calcimimetic AMG-073 on bone health in ESRD patients with secondary hyperparathyroidism (SHPT). J Am Soc Nephrol 2002;13:572A-3A.
-
(2002)
J Am Soc Nephrol
, vol.13
-
-
Quarles, L.1
Spiegel, D.2
Curzi, M.3
-
38
-
-
0041436108
-
Self-reported cognitive functioning in hemodialysis patients with secondary HPT: The effect of the calcimimetic AMG-073
-
Chertow G, Danese M, McCary L, Turner S. Self-reported cognitive functioning in hemodialysis patients with secondary HPT: The effect of the calcimimetic AMG-073. J Am Soc Nephrol 2002;13:633A.
-
(2002)
J Am Soc Nephrol
, vol.13
-
-
Chertow, G.1
Danese, M.2
McCary, L.3
Turner, S.4
-
39
-
-
26344440615
-
The SF-36 scales and the KDQOL cognitive functioning scale are reliable, valid and responsive in hemodialysis patients with secondary hyperparathyroidism
-
Lindberg J, Danese M, Spiegel D, Thezan G, Blaisdell P, Turner S. The SF-36 scales and the KDQOL cognitive functioning scale are reliable, valid and responsive in hemodialysis patients with secondary hyperparathyroidism. J Am Soc Nephrol 2002;13:702A.
-
(2002)
J Am Soc Nephrol
, vol.13
-
-
Lindberg, J.1
Danese, M.2
Spiegel, D.3
Thezan, G.4
Blaisdell, P.5
Turner, S.6
-
40
-
-
0036089693
-
Glandes parathyroïdes, récepteur du calcium et calcimimétiques
-
Ureña P. Glandes parathyroïdes, récepteur du calcium et calcimimétiques. Néphrologie 2002;23:151-64.
-
(2002)
Néphrologie
, vol.23
, pp. 151-164
-
-
Ureña, P.1
-
41
-
-
0035129796
-
Prevention of uremic bone disease using calcimimetic compounds
-
Olgaard K, Lewin E. Prevention of uremic bone disease using calcimimetic compounds. Annu Rev Med 2001;52:203-20.
-
(2001)
Annu Rev Med
, vol.52
, pp. 203-220
-
-
Olgaard, K.1
Lewin, E.2
|